Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics-Reference-Cited by-同舟云学术

Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics

Published:2021-02-18 Issue: Volume: Page:
ISSN:0006-341X
Container-title:Biometrics
language:en
Short-container-title:Biometrics

Author:

Gerard Emma¹²³^ORCID,Zohar Sarah¹^ORCID,Thai Hoai‐Thu⁴,Lorenzato Christelle²,Riviere Marie‐Karelle³,Ursino Moreno¹⁵^ORCID

Affiliation:

1. Centre de Recherche des Cordeliers Sorbonne Université Inserm, Université de Paris Paris F‐75006 France

2. Oncology Biostatistics, Biostatistics and Programming Department Sanofi R&D Vitry‐sur‐Seine France

3. Statistical Methodology Group, Biostatistics and Programming Department Sanofi R&D Chilly‐Mazarin France

4. Translation Disease Modeling, Digital and Data Science Sanofi R&D Chilly‐Mazarin France

5. F‐CRIN PARTNERS Platform, AP‐HP Université de Paris Paris France

Funder

Association Nationale de la Recherche et de la Technologie

Publisher

Wiley

Subject

Applied Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/biom.13433

Reference32 articles.

1. Bayesian Adaptive Methods for Clinical Trials

2. An open‐label, first‐in‐human, dose escalation study of a novel CD3‐CD123 bispecific T‐cell engager administered as a single agent by intravenous infusion in patients with relapsed or refractory acute myeloid leukemia, B‐cell acute lymphoblastic leukemia, or high risk myelodysplastic syndrome;Boissel N.;American Society of Clinical Oncology,2018

3. Simultaneously optimizing dose and schedule of a new cytotoxic agent

4. Determining a Maximum-Tolerated Schedule of a Cytotoxic Agent

5. Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moving the needle for oncology dose optimization: A call for action;Clinical and Translational Science;2024-06

2. Moving the needle for oncology dose optimization: A call for action;CPT: Pharmacometrics & Systems Pharmacology;2024-05-22

3. Moving the Needle for Oncology Dose Optimization: A Call for Action;Clinical Pharmacology & Therapeutics;2024-05-12

4. Adaptive phase I–II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapies;Clinical Trials;2024-01-11

5. An extended Bayesian semi‐mechanistic dose‐finding design for phase I oncology trials using pharmacokinetic and pharmacodynamic information;Statistics in Medicine;2023-12-18